Search

Patient Enrolled at the Cancer Clinical Trial Unit, CALHN, Royal Adelaide Hospital Aethlon's Trial is a Safety, Feasibility, and Dose Finding Study of the Hemopurifier in Patients with Solid Tumors [...]

WASHINGTON, Oct. 15, 2024 /PRNewswire/ -- The Lupus Foundation of America (LFA) is excited to announce Karen Costenbader, MD, MPH, Lupus Program Director, Brigham and Women's Hospital, Professor of Medicine [...]

SAN DIEGO, Oct. 8, 2024 /PRNewswire/ -- https://c212.net/c/link/?t=0&l=en&o=4272279-1&h=1538589197&u=https%3A%2F%2Furl.avanan.click%2Fv2%2F___https%3A%2Fwww.aethlonmedical.com%2F___.YXAzOmFldGhsb246YTpvOjFkMjcyYjUwZWU5NGJkMGIyNGNiMmE5MTAwODQ5MmI3OjY6OGVlZTozOTA3ODZlMTEzNWM3MTVhMGM4ODRjNTAzNjFlYjVmM2Q2MjFhOTllZGJkNmNiMjVjNzQ1OTRmNjhjOWFhZDQ2OnA6RjpO&a=Aethlon+Medical%2C+Inc.(Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that James Frakes, Chief [...]

In this free webinar, learn about the rapidly evolving landscape of Alzheimer's disease therapy development and treatment. Attendees will gain insights into the key considerations for various platforms and strategies [...]

Richard Riese, MD, PhD, and Ruxandra Draghia-Akli, MD, PhD, are joining Every Cure as Chief Medical Officer and Chair of the Scientific Advisory Board, respectively. PHILADELPHIA, Oct. 1, 2024 /PRNewswire/ [...]

In this free webinar, learn about current therapeutic vaccine research focusing on cancer and infectious disease indications. Attendees will gain insights into the unique requirements and best practices in therapeutic [...]

SAN DIEGO, Sept. 17, 2024 /PRNewswire/ -- https://c212.net/c/link/?t=0&l=en&o=4255048-1&h=1085448487&u=https%3A%2F%2Furl.avanan.click%2Fv2%2F___https%3A%2Fwww.aethlonmedical.com%2F___.YXAzOmFldGhsb246YTpvOjFkMjcyYjUwZWU5NGJkMGIyNGNiMmE5MTAwODQ5MmI3OjY6OGVlZTozOTA3ODZlMTEzNWM3MTVhMGM4ODRjNTAzNjFlYjVmM2Q2MjFhOTllZGJkNmNiMjVjNzQ1OTRmNjhjOWFhZDQ2OnA6RjpO&a=Aethlon+Medical%2C+Inc.(Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that management will present [...]

Aethlon's Trial is a Safety, Feasibility, and Dose Finding Study of the Hemopurifier in Patients with Solid Tumors Not Responding to Anti-PD-1 Antibodies SAN DIEGO, Sept. 16, 2024 /PRNewswire/ -- [...]

The study involved end-stage oncology patients with no other suitable treatment options. In this Phase Ib study, Pidnarulex (CX-5461) demonstrated acceptable clinical tolerability and showed preliminary signs of efficacy, even [...]

Community-led research by Global Heart Hub points at shared decision-making being critical when patients face their hypercholesterolemia diagnosis Patient community argues that putting more focus into that first discussion could [...]

Risk Predication Tool, Developed by Anesthesiologists at Montefiore Health System and Albert Einstein College Medicine, May Reduce Adverse Outcomes BRONX, N.Y., Aug. 23, 2024 /PRNewswire/ -- A new computational risk [...]

Risk Predication Tool, Developed by Anesthesiologists at Montefiore Health System and Albert Einstein College Medicine, May Reduce Adverse Outcomes BRONX, N.Y., Aug. 23, 2024 /PRNewswire-HISPANIC PR WIRE/-- A new computational [...]

PITTSBURGH, Aug. 6, 2024 /PRNewswire/ - https://c212.net/c/link/?t=0&l=en&o=4225614-1&h=744365763&u=https%3A%2F%2Fus.moleculight.com%2F&a=MolecuLight+Corp., the global leader in fluorescence imaging technology for real-time detection of harmful bacteria in wound care, announces the publication of peer-reviewed clinical research [...]

BALTIMORE, July 12, 2024 /PRNewswire/ -- University of Maryland Faculty Physicians has entered into an agreement to lease 17,000 square feet of space at The Village at Mondawmin, which would [...]

Will initiate a first-in-human Phase 1 clinical trial for INT2104, its first-in-class in vivo targeted gene therapy, creating CAR cells for the treatment of B cell malignancies in 4Q24 PHILADELPHIA, [...]

Team famous for HIV breakthroughs demonstrates both persistent COVID virus and widespread immune activation in long COVID; provides clear targets for treatment Key points: SARS-CoV-2 double-stranded RNA indicative of viral [...]

Study Featuring Cleveland Clinic Data Underscores the Importance of Treating Obesity as a Chronic Disease ORLANDO, Fla., June 21, 2024 /PRNewswire/ -- Today, data from a retrospective observational study conducted [...]

TREMFYA Phase 3 Crohn's disease study achieves all primary and secondary endpoints SPRING HOUSE, Pa., June 20, 2024 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced positive topline results [...]

PHILADELPHIA, June 18, 2024 /PRNewswire/ -- The Pew Charitable Trusts today announced the 2024 class of the Pew Latin American Fellows Program in the Biomedical Sciences. The 10 postdoctoral fellows [...]

Texas Biomed and partners licensing new SARS-CoV-2 antibody targeting newest strains of COVID-19 SAN ANTONIO, May 30, 2024 /PRNewswire/ -- SARS-CoV-2, the virus that causes COVID-19 disease, continues to evolve [...]

SHANGHAI, May 24, 2024 /PRNewswire/ -- Shanghai Juncell Therapeutics Co., Ltd. (Juncell Therapeutics), a clinical-stage biotech developing innovative Tumor-Infiltrating Lymphocyte (TIL) therapies for cancers, announced latest clinical research results on [...]

Major Milestone for EVÊîQ Nano's Biotech Arm Targeting Antibiotic-Resistant Bacterial Infections Linked to Cystic Fibrosis and Other Lung Diseases SALT LAKE CITY, May 15, 2024 /PRNewswire/ -- https://c212.net/c/link/?t=0&l=en&o=4167089-1&h=3506336415&u=https%3A%2F%2Fevoqnano.com%2F%23bio&a=EV%C5%8CQ+Bio, a wholly-owned [...]

GenScript continues to build on its fast and dependable in vitro transcription RNA synthesis service, offering a new self-amplifying RNA format that enhances the potency and efficacy of vaccines, immunotherapies, [...]

$5 million commitment will advance AHN's Living Health model in Cardiovascular medicine, driving leading-edge clinical care, research and technological innovations for patients with atrial fibrillation and other heart rhythm disorders [...]

Thompson Cancer Survival Center research brings new hope to patients. KNOXVILLE, Tenn., April 23, 2024 /PRNewswire/ -- Every treatment prescribed by a doctor today was once a part of research [...]

AHN Sleep Medicine Division Partners with Network's Cardiovascular Institute to Introduce Groundbreaking Technology for Heart Failure Patients Diagnosed with CSA PITTSBURGH, April 22, 2024 /PRNewswire-PRWeb/ -- Key Takeaways: Allegheny Health [...]

HEIDELBERG, Germany, April 18, 2024 /PRNewswire/ -- The European Wellness Biomedical Group (EWBG), in collaboration with the European Wellness Academy (EWA), the Baden Research Lab, and Heidelberg University, has announced [...]

Data Published in Therapeutic Advances in Urology Demonstrates Up to 96% Efficacy in Helping Restore Testosterone Levels to Normal at Day 90[sup.1*] RALEIGH, N.C., April 11, 2024 /PRNewswire/ -- https://c212.net/c/link/?t=0&l=en&o=4139111-1&h=3082454679&u=http%3A%2F%2Fwww.mariuspharma.com%2F&a=Marius+Pharmaceuticals, [...]

STOCKHOLM, April 10, 2024 /PRNewswire/ -- Gabather AB (Nasdaq First North Growth Market: GABA) announces that the Company has signed a Collaborative Agreement with the Centre for Neuropsychiatric Schizophrenia Research [...]

Topical pravibismane was found to be safe and well-tolerated for all doses tested in subjects with moderate to severely infected, chronic diabetic foot ulcers Pravibismane treatment demonstrated favorable trends towards [...]

TAIPEI and SAN DIEGO, March 20, 2024 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, announced [...]

FDA ODAC unanimously votes 11 to 0 supporting favorable risk-benefit assessment of CARVYKTIbased on results from the Phase 3 CARTITUDE-4 study RARITAN, N.J., March 15, 2024 /PRNewswire/ -- Johnson & [...]

Study presented at ATTD 2024 is the first of a planned series examining the impact of Dario's integrated cardiometabolic solution as a means to address weight and diabetes with or [...]

Maryland-based Pharmasite Research adds 20 years of psychiatric and central nervous system clinical research expertise to the site network SAN FRANCISCO, Feb. 29, 2024 /PRNewswire/ -- https://c212.net/c/link/?t=0&l=en&o=4103506-1&h=223284992&u=https%3A%2F%2Fheadlandsresearch.com%2F&a=Headlands+Research, a leading multinational [...]

BOWIE, Md., Feb. 21, 2024 /PRNewswire/ -- https://c212.net/c/link/?t=0&l=en&o=4095972-1&h=2765990351&u=https%3A%2F%2Fwww.inovalon.com%2F%3Futm_medium%3Dreferral%26utm_source%3Dpress-release%26utm_campaign%3DRH232607-%26utm_content%3Dhomepage&a=Inovalon, a leading provider of cloud-based software solutions empowering data-driven healthcare, today announced VigiLanz, an Inovalon solution and leading provider of SaaS-based clinical [...]

Aethlon Medical Will Perform Pre-Clinical Studies to Explore Potential Synergies With its First-in-Class Hemopurifier Blood Filtration System SAN DIEGO, Feb. 21, 2024 /PRNewswire/ -- https://c212.net/c/link/?t=0&l=en&o=4095896-1&h=2596990404&u=https%3A%2F%2Fwww.aethlonmedical.com%2F&a=Aethlon+Medical%2C+Inc.(Nasdaq: AEMD), a medical therapeutic company [...]

Task force outlines current health disparities and strategies to advance the patient experience across the continuum of care in newly issued call-to-action report. DALLAS, Feb. 21, 2024 /PRNewswire/ -- StopAfib.org, [...]

NEW YORK, Feb. 12, 2024 /PRNewswire/ -- https://c212.net/c/link/?t=0&l=en&o=4089238-1&h=1826781872&u=http%3A%2F%2Fwww.curavitclinicalresearch.com%2F&a=Curavit+Clinical+Research, a virtual contract research organization (VCRO) that specializes in decentralized clinical trials (DCTs) for digital therapeutics (DTx), has successfully completed a decentralized [...]

The company's platform expansion transforms the value of US healthcare data by harnessing real-time, regulatory-grade data in any therapeutic area to efficiently understand the complex medical histories of patients and [...]

The St. Baldrick's Foundation introduces its 2024 Ambassadors to raise awareness about the need to fund childhood cancer research to find cures and better treatments. LOS ANGELES, Jan. 3, 2024 [...]

Topline results expected 2Q 2024 Study enrolled a total of 241 patients; 109 catheter failures observed First-and-only antibiotic lock solution in development to salvage catheters in patients with CRBSI CRANFORD, [...]

TAIPEI and SAN DIEGO, Dec. 26, 2023 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, announced [...]

VANCOUVER, BC, Dec. 15, 2023 /PRNewswire/ - Numinus Wellness Inc. ('Numinus' or the 'Company') (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative behavioral health treatments [...]

DUBLIN, Nov. 23, 2023 /PRNewswire/ -- The https://www.researchandmarkets.com/report/prosthetic-joint-infection-drug?utm_source=CI&utm_medium=PressRelease&utm_code=n5ns5h&utm_campaign=1913173+-+Prosthetic+Joint+Infections+Pipeline+Research+Report+2023%3a+Comprehensive+Insights+on+5%2b+Companies+and+5+Drugs&utm_exec=chdo54prd clinical trials has been added toResearchAndMarkets.com's offering. This report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Prosthetic joint [...]

TAIPEI, Nov. 21, 2023 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, announced today that U.S. [...]

Company Reaches Important Product Development Milestone with its Myrna(TM) Instrument and TriVerity Cartridge SUNNYVALE, Calif., Nov. 15, 2023 /PRNewswire/ -- Inflammatix, Inc., a pioneering molecular diagnostics company, announced today that [...]

This will allow research and clinical trials centered on SARS-CoV-2 persistence as a driver of Long COVID to move to the next phase MEDFORD, Mass., Nov. 1, 2023 /PRNewswire/ -- [...]

Model Offers New Ways to Study Disease Impact and Treatment Approaches NEW YORK, Nov. 1, 2023 /PRNewswire/ -- Researchers have genetically engineered the first mice that get a human-like form [...]

First Major Milestone Met in Trial to Inform Neoadjuvant Targeted Therapy Options for Early-Stage Lung Cancer Patients NEW YORK, Oct. 24, 2023 /PRNewswire/ -- The Lung Cancer Mutation Consortium (LCMC), [...]

Niraparib and abiraterone acetate plus prednisone combination therapy also showed clinically relevant improvement versus standard of care in time to symptomatic progression and time to cytotoxic chemotherapy MADRID, Oct. 22, [...]